Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2ACS DOBFAR SPA

02 1ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD

03 4Barr Laboratories

04 7Bio Labs

05 15Bristol Myers Squibb

06 2ERSANA

07 4GSK

08 1Hainan Haiyao

09 2IVAX Pharmaceuticals Inc

10 2Jodas Expoim Pvt. Ltd

11 2Nectar Lifesciences

12 4Teva Pharmaceutical Industries

13 2VITARINE

14 1Yangtze River Pharmaceutical Group

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF

Dosage Form : TABLET;ORAL

Dosage Strength : 1GM

Packaging :

Approval Date : 1982-01-01

Application Number : 50530

Regulatory Info : DISCN

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF 125

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 125MG/5ML

Packaging :

Approval Date : 1982-01-01

Application Number : 61763

Regulatory Info : DISCN

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF 250

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 250MG/5ML

Packaging :

Approval Date : 1982-01-01

Application Number : 61763

Regulatory Info : DISCN

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1982-01-01

Application Number : 61764

Regulatory Info : DISCN

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF

Dosage Form : CAPSULE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 1982-01-01

Application Number : 61764

Regulatory Info : DISCN

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 250MG/VIAL

Packaging :

Approval Date : 1982-01-01

Application Number : 61976

Regulatory Info : DISCN

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 500MG/VIAL

Packaging :

Approval Date : 1982-01-01

Application Number : 61976

Regulatory Info : DISCN

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2GM/VIAL

Packaging :

Approval Date : 1982-01-01

Application Number : 61976

Regulatory Info : DISCN

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1GM/VIAL

Packaging :

Approval Date : 1982-01-01

Application Number : 61976

Regulatory Info : DISCN

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 4GM/VIAL

Packaging :

Approval Date : 1982-01-01

Application Number : 61976

Regulatory Info : DISCN

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : ANSPOR

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1982-01-01

Application Number : 61859

Regulatory Info : DISCN

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : ANSPOR

Dosage Form : CAPSULE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 1982-01-01

Application Number : 61859

Regulatory Info : DISCN

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : ANSPOR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 125MG/5ML

Packaging :

Approval Date : 1982-01-01

Application Number : 61866

Regulatory Info : DISCN

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : ANSPOR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 250MG/5ML

Packaging :

Approval Date : 1982-01-01

Application Number : 61866

Regulatory Info : DISCN

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : CEPHRADINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1987-01-09

Application Number : 62683

Regulatory Info : DISCN

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : CEPHRADINE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 1987-01-09

Application Number : 62683

Regulatory Info : DISCN

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : CEPHRADINE

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 125MG/5ML

Packaging :

Approval Date : 1987-01-09

Application Number : 62693

Regulatory Info : DISCN

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : CEPHRADINE

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 250MG/5ML

Packaging :

Approval Date : 1987-01-09

Application Number : 62693

Regulatory Info : DISCN

Registration Country : USA

blank

19

ERSANA

Country
2024 ACI Convention
Not Confirmed
arrow

ERSANA

Country
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF 250

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1982-01-01

Application Number : 50548

Regulatory Info : DISCN

Registration Country : USA

blank

20

ERSANA

Country
2024 ACI Convention
Not Confirmed
arrow

ERSANA

Country
arrow
2024 ACI Convention
Not Confirmed

CEPHRADINE

Brand Name : VELOSEF 500

Dosage Form : CAPSULE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 1982-01-01

Application Number : 50548

Regulatory Info : DISCN

Registration Country : USA

blank